Literature DB >> 4011142

Botulinum toxin injection in the management of lateral rectus paresis.

A B Scott, S P Kraft.   

Abstract

Seventeen patients with lateral rectus paresis (3 bilateral) were treated by injection of botulinum toxin to the antagonist medial rectus to eliminate its unopposed action or to eliminate its contracture. This allowed maintenance of single binocular vision in most patients while waiting for the palsy to heal, especially important in two children. It allowed avoidance of surgery in some cases, and a reduction or elimination of medial rectus surgery when later intervention was needed for persistent paralysis. The release of medial rectus shortening and stiffness (contracture) after just a few days of denervation was unexpected. This implies an internal muscular mechanism of contracture, perhaps sarcomere overlap, different from the fibrotic changes found in muscles after inflammation or trauma. These results also provide a rationale for experimental denervation treatment of contracture in limb muscle disorders.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4011142     DOI: 10.1016/s0161-6420(85)33982-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  23 in total

1.  Lateral rectus posterior fixation suture.

Authors:  Jonathan M Holmes; Sarah R Hatt; David A Leske
Journal:  J AAPOS       Date:  2010-04       Impact factor: 1.220

2.  Botulinum toxin treatment of acute sixth and third nerve palsy.

Authors:  H S Metz; M Mazow
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

3.  Isolated abducens nerve paresis associated with high titer of anti-asialo-GM1 following Campylobacter jejuni enteritis.

Authors:  Juri Katchanov; Jan Dirks Lünemann; Florian Masuhr; Andreas Meisel; Helgard Möller; Rolf Zschenderlein
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

4.  Inferior rectus paresis and medial rectus overaction following retrobulbar anesthesia for cataract surgery.

Authors:  R Muralidhar; P Vijayalakshmi; Anil K Gunda
Journal:  Int Ophthalmol       Date:  2010-02-03       Impact factor: 2.031

5.  Dissociated effects of botulinum toxin chemodenervation on ocular deviation and saccade dynamics in chronic lateral rectus palsy.

Authors:  J F Acheson; C R Bentley; J Shallo-Hoffmann; M A Gresty
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

6.  Predictors of Good Motor and Sensory Outcomes Following Strabismus Surgery for Patients with Third Nerve Palsies.

Authors:  Jason H Peragallo; Beau B Bruce; Amy K Hutchinson; Phoebe D Lenhart; Valérie Biousse; Nancy J Newman; Scott R Lambert
Journal:  Neuroophthalmology       Date:  2014-10-09

7.  Functional and Motor Outcomes of Strabismus Surgery for Chronic Isolated Adult Sixth Nerve Palsy.

Authors:  Jason H Peragallo; Beau B Bruce; Amy K Hutchinson; Phoebe D Lenhart; Valérie Biousse; Nancy J Newman; Scott R Lambert
Journal:  Neuroophthalmology       Date:  2014-10-09

8.  Botulinum toxin: a new ally of an old adversary.

Authors:  R C Humphry
Journal:  BMJ       Date:  1989-01-21

9.  Augmented vertical recti transposition with intraoperative botulinum toxin for complete and chronic sixth nerve palsy.

Authors:  R Nabie; D Andalib
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

10.  Botulinum toxin type A in the treatment of patients with cervical dystonia.

Authors:  Allison Brashear
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.